| Completed | INDV-6001 Multiple-Dose Pharmacokinetic Study Moderate to Severe Opioid Use Disorder | Phase 2 | 2024-09-17 |
| Completed | Proof of Concept and Dose-ranging Study of INDV-2000 in Individuals With Moderate to Severe Opioid Use Disorde Opioid Use Disorder | Phase 2 | 2024-06-10 |
| Completed | Evaluating the SUBLOCADE Treatment Exit Strategy Opioid Use Disorder | — | 2023-11-24 |
| Completed | SUBLOCADE Long-term Outcomes Opioid Use Disorder | — | 2023-08-31 |
| Completed | Single Dose Study of [14C]-IDV184001AN ([14C]-IDV184001) in Healthy Adult Male Participants Opioid Use Disorder | Phase 1 | 2023-07-10 |
| Completed | Study of Potential CYP3A4 Induction by INDV-2000 in Healthy Adults Healthy | Phase 1 | 2023-03-16 |
| Completed | Evaluation of Buprenorphine Extended-Release Subcutaneous Injection at Alternative Injection Locations Opioid Use Disorder | Phase 4 | 2023-03-01 |
| Completed | Study to Assess Repeated Doses of INDV-2000 in Healthy Volunteers and in Treatment Seeking Individuals With Op Healthy Volunteer, Opioid-use Disorder | Phase 1 | 2022-08-17 |
| Completed | Buprenorphine Extended-Release Subcutaneous Injection (RBP-6000) in High-risk Users Moderate to Severe Opioid-use Disorder | Phase 4 | 2021-10-26 |
| Terminated | An Observational Study of Environmental and Socioeconomic Factors in Opioid Recovery - Long Term Opioid Use Disorder | — | 2020-09-20 |
| Completed | INDV-2000 First in Human Opioid Dependence | Phase 1 | 2020-07-06 |
| Completed | SUBLOCADE Rapid Initiation Extension Study Opioid Use Disorder, Severe, Opioid Use Disorder, Moderate | Phase 4 | 2019-10-21 |
| Completed | SUBLOCADE Rapid Initiation Study Opioid-use Disorder | Phase 4 | 2019-08-29 |
| Completed | Safety, Tolerability, Pharmacokinetics and Efficacy of 180 mg Subcutaneous Risperidone From 6 mg Oral Risperid Schizophrenia | Phase 4 | 2019-06-28 |
| Completed | Evaluation of Long-term Buprenorphine Plasma Exposure Opioid-use Disorder | — | 2019-02-19 |
| Completed | Buprenorphine-Fentanyl Interaction Study Healthy, Opioid Use | Phase 1 | 2018-03-22 |
| Completed | Study of a Novel Subcutaneous Depot Formulation of Buprenorphine Opioid-use Disorder | Phase 1 | 2017-09-20 |
| Completed | A Phase 1 Bioavailability Study of Arbaclofen Placarbil Modified Release Formulations in Healthy Volunteers Healthy Volunteers | Phase 1 | 2017-01-24 |
| Completed | Open-Label Treatment Extension Study Opioid Use Disorder, Opioid-related Disorders | Phase 3 | 2016-08-17 |
| Completed | PK, Safety, and Tolerability Study of RBP-7000 of Different Molecular Weight Polymer in Subjects With Schizoph Schizophrenia | Phase 1 | 2016-02-01 |
| Completed | Pharmacokinetics, Safety, and Tolerability of Depot Buprenorphine at Three Different Molecular Weights in Trea Opioid Use Disorder | Phase 1 | 2015-09-01 |
| Completed | A Dose-Escalation Study to Determine the Maximum Tolerated Dose of Arbaclofen Placarbil in Subjects With Alcoh Alcohol Use Disorder | Phase 2 | 2015-09-01 |
| Completed | An Observational Study of Environmental and SocioEconomic Factors in Opioid Recovery Opioid-use Disorder, Opioid-related Disorders | — | 2015-08-01 |
| Completed | Safety and Tolerability Study of Depot Buprenorphine in Treatment Seeking Subjects With Opioid Use Disorder Opioid Use Disorder, Opioid-related Disorders | Phase 3 | 2015-07-27 |
| Completed | Treatment Seeking Participants With Opioid Use Disorders Assessing Tolerability of Depot Injections of Bupreno Opioid Dependence, Opioid Related Disorders | Phase 3 | 2015-01-28 |
| Completed | Long Term Study of RBP 7000 in the Treatment of Subjects With Schizophrenia Schizophrenia | Phase 3 | 2014-06-01 |
| Completed | Randomized, Double-blind, Placebo Controlled, Multi-center and Tolerability of RBP-7000 in Schizophrenia Patie Schizophrenia | Phase 3 | 2014-04-01 |
| Completed | Usability of Zubsolv Sublingual Tablets 5.7/1.4 to Suboxone Sublingual Film 8/2 In Buprenorphine/Naloxone Trea Opioid Dependence | Phase 4 | 2013-11-01 |
| Completed | Multiple Dose Study of Blockade of Opioid Effects by Injections of Buprenorphine in Participants With Opioid D Opioid Use Disorder | Phase 2 | 2013-11-01 |
| Completed | A Randomized, 4-sequence, 2-period, Double-blind, Placebo Controlled Study With a DSM-IV-TR Diagnosis of Cocai Opioid Dependence, Opioid Related Disorders, Cocaine Dependence | Phase 2 | 2013-04-01 |
| Completed | Multiple Dose Pharmacokinetics Depot Buprenorphine in Opioid-Dependent Subjects Opioid Related Disorder | Phase 2 | 2012-10-01 |
| Completed | Single Dose Pharmacokinetics of Suboxone Study in Hepatic Impaired Subjects Hepatic Failure, Hepatic Impairment, Chronic Hepatitis C Infection With Hepatic Coma | Phase 4 | 2012-09-01 |
| Completed | Multiple Ascending Dose Study of the Safety, Tolerability, Pharmacokinetic/Efficacy Schizophrenia | Phase 2 | 2012-08-01 |
| Completed | Single Ascending Dose Study of RBP-6000 Opioid Use Disorder | Phase 1 | 2012-07-01 |
| Completed | Transfer of Subjects From Subutex/Suboxone to RBP-6300 Opioid Related Disorder | Phase 2 | 2012-03-01 |
| Completed | Single Ascending Dose Study of RBP-7000 Schizophrenia | Phase 1 | 2011-04-01 |
| Completed | Single-dose, Study of RBP-6000 in Opioid Dependent Individuals Opioid Use Disorder | Phase 1 | 2010-11-01 |
| Completed | First in Man Study of Safety, Tolerability and PK Profile of RBP-7000 Schizophrenia | Phase 1 | 2010-03-01 |
| Completed | Effectiveness of Buprenorphine/Naloxone in Reducing Intravenous Buprenorphine Misuse in France ("RIME") Opioid Dependency | Phase 4 | 2009-08-01 |
| Completed | Multicentre Trial of Suboxone in Opiate-dependent Subjects in Taiwan Opiate Dependence | Phase 4 | 2009-03-01 |
| Completed | Acceptability and Safety of Switching From Subutex or Other Opioid Drug Dependence Therapy to Suboxone (NIS P0 Opioid-Related Disorders, Opiate Dependence, Drug Abuse | — | 2008-05-01 |
| Completed | A Randomized Acceptability and Safety Study of the Transfer From Subutex to Suboxone in Opioid- Dependent Subj Opiate Dependence, Drug Dependence | Phase 4 | 2008-03-01 |
| Completed | Induction of Opioid-Dependent Individuals Onto Buprenorphine and Buprenorphine/Naloxone Opioid-related Disorders | Phase 2 | 2008-03-01 |
| Completed | Treatment of Opioid Dependent Patients With Suboxone: Acceptability & Safety Data From Real Life Scenario (Stu Opioid-Related Disorders, Opiate Dependence, Drug Abuse | — | 2008-03-01 |
| Completed | Safety and Tolerability of Buprenorphine/Naloxone Film Strips Opioid-Related Disorders | Phase 2 | 2008-02-01 |
| Completed | Preference for Subutex® (Buprenorphine) Versus Suboxone® (Buprenorphine/Naloxone) in Opioid Dependent Patients Opiate-related Disorders, Opiate Dependence, Drug Abuse | Phase 4 | 2007-07-01 |
| Completed | Observational Study of Misuse of High Dose Buprenorphine (Subutex® or Generic) in Opiate-Addicted Patients in Buprenorphine, Naloxone, Opiate-related Disorders | — | 2007-05-01 |
| Completed | Survey of Buprenorphine Use Among "Out of Care" Population in France (P04933)(COMPLETED) Drug Addiction | — | 2006-06-01 |
| Completed | A Study to Evaluate the Efficacy and Safety of Controlled Release Arbaclofen Placarbil (XP19986) in Patients W GERD | Phase 2 | 2005-10-01 |
| Completed | Study of Two Formulations of Buprenorphine HCl in Opioid-dependent Subjects on Buprenorphine Maintenance Thera Opioid Dependency | Phase 2 | 2005-09-01 |
| Terminated | Buprenorphine Versus Methadone Maintenance in Hepatitis C Patients Receiving Peg-Intron and Rebetol (Study P04 Hepatitis C, Chronic | Phase 4 | 2005-08-01 |